This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Sansana Sawasdikosol
Introduction
Sansana Sawasdikosol is a prominent inventor based in New York, NY. He has made significant contributions to the field of biomedical research, particularly in the development of compounds that target specific diseases. His work is characterized by a focus on innovative solutions that address critical health challenges.
Latest Patents
Sansana Sawasdikosol holds a patent for "Heterobifunctional compounds as degraders of HPK1." This patent discloses Hematopoietic Progenitor Kinase 1 (HPK1) degradation/disruption compounds, which include a HPK1 ligand, a degradation/disruption tag, and a linker. The methods for using these compounds are aimed at treating HPK1-mediated diseases. He has 1 patent to his name.
Career Highlights
Sansana is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts his research. His work has been instrumental in advancing the understanding of HPK1 and its role in various diseases. His innovative approach has garnered attention in the scientific community.
Collaborations
He has collaborated with notable colleagues, including Jian Jin and Steven Burakoff. These partnerships have enhanced the scope and impact of his research, leading to advancements in the field.
Conclusion
Sansana Sawasdikosol's contributions to biomedical research exemplify the importance of innovation in addressing health issues. His work continues to inspire future research and development in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile